Page 16 - ப்ரைம் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Annual Changes To The Nasdaq Biotechnology Index
Date
11/12/2020
Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020.
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
The following 100 securities will be added to the Index:
EXCHANGE ....

Pliant Therapeutics Inc , Zentalis Pharmaceuticals Inc , Gritstone Oncology Inc , Poseida Therapeutics Inc , Oncology Holdings Inc , Nextcure Inc , Cortexyme Inc , Molecular Transport Inc , Phibro Animal Health Corporation , Evolus Inc , Passage Bio Inc , Constellation Pharmaceuticals Inc , Bio Techne Corp , Allovir Inc , Verastem Inc , Nantkwest Inc , Optinose Inc , Cerus Corporation , Sutro Biopharma Inc , Marinus Pharmaceuticals Inc , Kamada Ltd , Vir Biotechnology Inc , Teos Therapeutics Inc , Beam Therapeutics Inc , Annexon Inc , Ocular Therapeutix Inc ,